EcoDrugPlus

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSDCDG00000030109
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyridine-Sensitive L-Type Skeletal Muscle Calcium Channel Subunit Alpha-1-Like

Ensembl ID : ENSDCDG00000018115
Gene Symbol: LOC114800487
3 Cross references
196 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSDCDG00000018309
Gene Symbol: DPYD
3 Cross references
214 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSDCDG00000020647
Gene Symbol: DDR2
3 Cross references
205 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSDCDG00000016305
Gene Symbol: DDR2
3 Cross references
190 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSDCDG00000022194
Gene Symbol: DRD1
1 Cross references
189 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSDCDG00000000187
Gene Symbol: DRD2
3 Cross references
207 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSDCDG00000000306
Gene Symbol: DRD3
3 Cross references
203 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSDCDG00000023936
Gene Symbol: DRD5
3 Cross references
164 Possible Orthologues:

Dual Specificity Mitogen-Activated Protein Kinase Kinase 2-Like

Ensembl ID : ENSDCDG00000028530
Gene Symbol: LOC114788193
3 Cross references
202 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSDCDG00000014497
Gene Symbol: ENPP2
3 Cross references
225 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSDCDG00000029486
Gene Symbol: ENPP2
3 Cross references
225 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).